|
MechanismAT1R antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date22 Dec 1997 |
100 Clinical Results associated with Viatris Pharma GmbH
0 Patents (Medical) associated with Viatris Pharma GmbH
100 Deals associated with Viatris Pharma GmbH
100 Translational Medicine associated with Viatris Pharma GmbH